Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Agoracom Moderator

Yes certainly. Most likely the next PR will be of the recert and explanation of 336 claims left in tact. That should be good news indeed.

Share
New Message
Please login to post a reply